Literature DB >> 4387392

Some studies on cytisine and its methylated derivatives.

R B Barlow, L J McLeod.   

Abstract

1. In mice cytisine hydrochloride is less toxic intravenously than nicotine hydrogen tartrate, but more toxic by intraperitoneal or oral administration. Compared with cytisine, caulophylline hydrogen iodide is one-fifth to one-tenth as toxic and caulophylline methiodide is less than one-thirtieth as toxic.2. The surprising low oral toxicity of cytisine and nicotine may be ascribed to the method of administration; if the drug is placed directly in the stomach there is no possibility of absorption through buccal mucous membranes.3. The peripheral effects of nicotine, cytisine and caulophylline are similar, though on some preparations those of nicotine last longer. In most tests cytisine is active in doses from a quarter to three-quarters of those of nicotine, caulophylline in doses from 10 to 20 times those of cytisine. Caulophylline methiodide is virtually inactive.4. Cytisine and caulophylline may differ from nicotine in their central effects.5. Cytisine and caulophylline are active as the cations. The pKa of cytisine is 7.92 and that of caulophylline is 7.04; the difference accounts, in part, for the weaker activity of caulophylline. The caulophylline ion is generally one-sixth to one-third as active as the cytisine ion.6. The introduction of the second methyl group to form the quaternary salt does not appear to cause a dramatic change in the conformation of the molecule. Caulophylline methiodide appears to be feebly active because it has feeble affinity.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4387392      PMCID: PMC1703083          DOI: 10.1111/j.1476-5381.1969.tb07977.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  The influence of pH on the activity of nicotine at the neuromuscular junction.

Authors:  J T HAMILTON
Journal:  Can J Biochem Physiol       Date:  1963-02

2.  The isolated chick biventer cervicis nerve-muscle preparation.

Authors:  B L GINSBORG; J WARRINER
Journal:  Br J Pharmacol Chemother       Date:  1960-09

3.  The relationship between depolarization and block in the cat's superior cervical ganglion.

Authors:  W D M PATON; W L M PERRY
Journal:  J Physiol       Date:  1953-01       Impact factor: 5.182

4.  A method of recording the respiration.

Authors:  J H Gaddum
Journal:  J Physiol       Date:  1941-01-14       Impact factor: 5.182

5.  Laburnum poisoning in children; report on ten cases.

Authors:  R G MITCHELL
Journal:  Lancet       Date:  1951-07-14       Impact factor: 79.321

6.  A molecular orbital calculation of the preferred conformation of nicotine.

Authors:  L B Kier
Journal:  Mol Pharmacol       Date:  1968-01       Impact factor: 4.436

7.  The affinity and efficacy of onium salts on the frog rectus abdominis.

Authors:  R B Barlow; N C Scott; R P Stephenson
Journal:  Br J Pharmacol Chemother       Date:  1967-09

8.  SOME EFFECTS OF LONG CHAIN POLYMETHYLENE BISONIUM SALTS ON JUNCTIONAL TRANSMISSION IN THE PERIPHERAL NERVOUS SYSTEM.

Authors:  R B BARLOW; A ZOLLER
Journal:  Br J Pharmacol Chemother       Date:  1964-08
  8 in total
  21 in total

1.  Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.

Authors:  Sheela K Chellappan; Yingxian Xiao; Werner Tueckmantel; Kenneth J Kellar; Alan P Kozikowski
Journal:  J Med Chem       Date:  2006-05-04       Impact factor: 7.446

2.  The inadequacy of the reductionist approach in discovering new therapeutic agents against complex diseases.

Authors:  Manuel X Duval
Journal:  Exp Biol Med (Maywood)       Date:  2018-08-08

3.  Patterns of nicotinic receptor antagonism: nicotine discrimination studies.

Authors:  Emily M Jutkiewicz; Emily A Brooks; Adam D Kynaston; Kenner C Rice; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2011-07-05       Impact factor: 4.030

Review 4.  Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions.

Authors:  Dympna Harmey; Patrick R Griffin; Paul J Kenny
Journal:  Nicotine Tob Res       Date:  2012-09-27       Impact factor: 4.244

5.  Ethnopharmacological table on some reputedly psychoactive fumigatories among Middle and South American natives.

Authors:  P A De Smet
Journal:  Pharm Weekbl Sci       Date:  1985-10-25

6.  The affinity and activity of compounds related to nicotine on the rectus abdominis muscle of the frog (Rana pipiens).

Authors:  R B Barlow; G M Thompson; N C Scott
Journal:  Br J Pharmacol       Date:  1969-11       Impact factor: 8.739

7.  Varenicline for smoking cessation: efficacy, safety, and treatment recommendations.

Authors:  Jon O Ebbert; Kirk D Wyatt; J Taylor Hays; Eric W Klee; Richard D Hurt
Journal:  Patient Prefer Adherence       Date:  2010-10-05       Impact factor: 2.711

8.  Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor.

Authors:  J A Pratt; I P Stolerman; H S Garcha; V Giardini; C Feyerabend
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Characterization of the receptor mediating the nicotine discriminative stimulus.

Authors:  C Romano; A Goldstein; N P Jewell
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 10.  Smoking cessation therapy with varenicline.

Authors:  Uma M Mohanasundaram; Rajinder Chitkara; Ganesh Krishna
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.